Twenty-three CD4+ gsTcell clones isolated from biopsies from patients with active CeD were cultured and stimulated in vitro and used to perform transcriptomic (RNA-Seq; n = 23) and targeted proteomics analysis (n = 3) (discovery cohort, Suppl. Here, CD4 is linked to cranioectodermal dysplasia.